Skip to main content
Top
Published in: Osteoporosis International 1/2011

Open Access 01-01-2011 | Original Article

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Authors: E. S. Siris, S. Gehlbach, J. D. Adachi, S. Boonen, R. D. Chapurlat, J. E. Compston, C. Cooper, P. Delmas, A. Díez-Pérez, F. H. Hooven, A. Z. LaCroix, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, K. G. Saag, P. Sambrook, S. Silverman, N. B. Watts, A. Wyman, S. L. Greenspan

Published in: Osteoporosis International | Issue 1/2011

Login to get access

Abstract

Summary

We compared self-perception of fracture risk with actual risk among 60,393 postmenopausal women aged ≥55 years, using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Most postmenopausal women with risk factors failed to appreciate their actual risk for fracture. Improved education about osteoporosis risk factors is needed.

Introduction

This study seeks to compare self-perception of fracture risk with actual risk among postmenopausal women using data from GLOW.

Methods

GLOW is an international, observational, cohort study involving 723 physician practices in 17 sites in ten countries in Europe, North America, and Australia. Participants included 60,393 women ≥55 years attended by their physician during the previous 24 months. The sample was enriched so that two thirds were ≥65 years. Baseline surveys were mailed October 2006 to February 2008. Main outcome measures were self-perception of fracture risk in women with elevated risk vs women of the same age and frequency of risk factors for fragility fracture.

Results

In the overall study population, 19% (10,951/58,434) of women rated their risk of fracture as a little/much higher than that of women of the same age; 46% (27,138/58,434) said it was similar; 35% (20,345/58,434) believed it to be a little/much lower. Among women whose actual risk was increased based on the presence of any one of seven risk factors for fracture, the proportion who recognized their increased risk ranged from 19% for smokers to 39% for current users of glucocorticoid medication. Only 33% (4,185/12,612) of those with ≥2 risk factors perceived themselves as being at higher risk. Among women reporting a diagnosis of osteopenia or osteoporosis, only 25% and 43%, respectively, thought their risk was increased.

Conclusion

In this international, observational study, most postmenopausal women with risk factors failed to appreciate their actual risk for fracture.
Literature
1.
go back to reference NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef
2.
go back to reference Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578CrossRefPubMed Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578CrossRefPubMed
4.
go back to reference Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778CrossRefPubMed Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778CrossRefPubMed
5.
go back to reference Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305CrossRefPubMed Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305CrossRefPubMed
6.
go back to reference Phillipov G, Phillips PJ, Leach G, Taylor AW (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556CrossRefPubMed Phillipov G, Phillips PJ, Leach G, Taylor AW (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556CrossRefPubMed
7.
go back to reference Gerend MA, Erchull MJ, Aiken LS, Maner JK (2006) Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis. Maturitas 55:227–237CrossRefPubMed Gerend MA, Erchull MJ, Aiken LS, Maner JK (2006) Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis. Maturitas 55:227–237CrossRefPubMed
8.
go back to reference Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD (2008) Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskeletal Disorders 9:38CrossRefPubMed Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD (2008) Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskeletal Disorders 9:38CrossRefPubMed
9.
go back to reference Kanis JA, on behalf of the World Health Organisation Scientific Group (2008) Assessment of osteoporosis at the primary health care level. WHO Scientific Group Technical Report, Who Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK (available on request from the WHO Collaborating Centre or the IOF) Kanis JA, on behalf of the World Health Organisation Scientific Group (2008) Assessment of osteoporosis at the primary health care level. WHO Scientific Group Technical Report, Who Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK (available on request from the WHO Collaborating Centre or the IOF)
10.
go back to reference Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris E, Watts NB, Anderson FA Jr (2009) The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int 20:1107–1116CrossRefPubMed Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris E, Watts NB, Anderson FA Jr (2009) The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int 20:1107–1116CrossRefPubMed
11.
go back to reference Haentjens P, Johnell O, Kanis JA, Bouillon R, Cooper C, Lamraski G, Vanderschueren D, Kaufman JM, Boonen S (2004) Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men. J Bone Miner Res 19:1933–1944CrossRefPubMed Haentjens P, Johnell O, Kanis JA, Bouillon R, Cooper C, Lamraski G, Vanderschueren D, Kaufman JM, Boonen S (2004) Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men. J Bone Miner Res 19:1933–1944CrossRefPubMed
12.
go back to reference EuroQol Group (1990) EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy (Amsterdam, Netherlands) 16:199–208 EuroQol Group (1990) EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy (Amsterdam, Netherlands) 16:199–208
13.
go back to reference Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36 Heath Survey. Quality Metric, Lincoln Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36 Heath Survey. Quality Metric, Lincoln
14.
go back to reference Satterfield T, Johnson SM, Slovic P, Neil N, Schein JR (2000) Perceived risks and reported behaviors associated with osteoporosis and its treatment. Women Health 31:21–40CrossRefPubMed Satterfield T, Johnson SM, Slovic P, Neil N, Schein JR (2000) Perceived risks and reported behaviors associated with osteoporosis and its treatment. Women Health 31:21–40CrossRefPubMed
15.
go back to reference Gerend MA, Aiken LS, West SG, Erchull MJ (2004) Beyond medical risk: investigating the psychological factors underlying women's perceptions of susceptibility to breast cancer, heart disease, and osteoporosis. Health Psychol 23:247–258CrossRefPubMed Gerend MA, Aiken LS, West SG, Erchull MJ (2004) Beyond medical risk: investigating the psychological factors underlying women's perceptions of susceptibility to breast cancer, heart disease, and osteoporosis. Health Psychol 23:247–258CrossRefPubMed
16.
go back to reference Cline RR, Farley JF, Hansen RA, Schommer JC (2005) Osteoporosis beliefs and antiresorptive medication use. Maturitas 50:196–208CrossRefPubMed Cline RR, Farley JF, Hansen RA, Schommer JC (2005) Osteoporosis beliefs and antiresorptive medication use. Maturitas 50:196–208CrossRefPubMed
18.
go back to reference van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed
19.
go back to reference Dunn BK, Ryan A (2009) Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators. Ann NY Acad Sci 1155:141–161CrossRefPubMed Dunn BK, Ryan A (2009) Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators. Ann NY Acad Sci 1155:141–161CrossRefPubMed
Metadata
Title
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Authors
E. S. Siris
S. Gehlbach
J. D. Adachi
S. Boonen
R. D. Chapurlat
J. E. Compston
C. Cooper
P. Delmas
A. Díez-Pérez
F. H. Hooven
A. Z. LaCroix
J. C. Netelenbos
J. Pfeilschifter
M. Rossini
C. Roux
K. G. Saag
P. Sambrook
S. Silverman
N. B. Watts
A. Wyman
S. L. Greenspan
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 1/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1211-8

Other articles of this Issue 1/2011

Osteoporosis International 1/2011 Go to the issue